MedTrace Logo

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

NCT04472338 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2026-05-15

No results posted yet for this study

Summary

This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help identify ways to detect cancer earlier, thereby improving treatment and methods of early detection in the future.

Conditions

  • Prostate Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood, urine, and/or tissue samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • University of Washington

    lead OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Canary Foundation

    collaborator OTHER

  • CureBRCA

    collaborator UNKNOWN

Principal Investigators

  • Heather H. Cheng, MD, PhD · Fred Hutch/University of Washington Cancer Consortium

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-21
Primary Completion
2030-08-31
Completion
2030-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04472338 on ClinicalTrials.gov